More About Northstar
Our Services
FAB-DT for SEPSIS
Northstar has invented Fab-DT, a way to use antibody fragments as a rapid point-of-care diagnostic and treatment paradigm at the bedside. We are innovating new ways to tackle sepsis and antimicrobial resistance.
FAB-DT for Bioterrorism Countermeasure
Northstar‘s diagnostic and therapeutic antibody fragment paradigm is reimagining point-of-incident bioterrorism countermeasure. Rapid diagnosis and treatment will save lives, protecting our troops, civilians and assets.
PARTNERING
We are always seeking partners for antibody design, testing and scaled production.
Northstar News
MILESTONES:
2025, 2026: MTA with University of Notre Dame & Tetracore
Nov 2024: Fab-DT Poster Presentation at BARDA Meeting
Aug 2023: Fab-DT Tech Watch Light call with BARDA
June 2023: Fab-DT Product Pitch at TechConnect World Innovation Conference & Expo
May 2023: Fab-DT Poster Presentation at MTEC Meeting, Richmond, VA
Mar 2023: NDA with University of Pittsburgh
June 2021: Fab-DT Submission to USPTO
Upcoming events
Stay tuned....
FAQs
For more insight into Fab-DT, please contact us to set up a meeting.